ReCor Responds to European Society of Hypertension’s (ESH) Updated Guidelines for Management of Arterial Hypertension

ReCor Medical, Inc. (“ReCor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) are pleased to see the updated and expanded recommendations for the management of arterial hypertension that The European Society of Hypertension (ESH) presented at their…

Read MoreReCor Responds to European Society of Hypertension’s (ESH) Updated Guidelines for Management of Arterial Hypertension

Cardio Diagnostics Holdings, Inc and RiverRock Medical Partner to Bring Epigenetic-Genetic Heart Disease Testing to Austin, Texas

Cardio Diagnostics Holdings,Inc. (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, announced a partnership with Austin, Texas-based concierge, and executive health practice, RiverRock Medical. This partnership establishes RiverRock Medical as the first service provider in Austin, Texas, to…

Read MoreCardio Diagnostics Holdings, Inc and RiverRock Medical Partner to Bring Epigenetic-Genetic Heart Disease Testing to Austin, Texas

Commonwealth Radiology Associates Announces New Partnership with York Hospital

Commonwealth Radiology Associates (CRA), the premier private practice radiology group in northern New England, today announces a new partnership where the group will provide comprehensive radiology services to York Hospital in York, Maine. Located in the greater-Boston area, Commonwealth Radiology Associates’ specialty-trained…

Read MoreCommonwealth Radiology Associates Announces New Partnership with York Hospital

Global Sinus Dilation Devices Market 2023 to 2028: Players Include Dalent Medical, Emos Technology, Entermed BV and Fentexmedical – ResearchAndMarkets.com

The global sinus dilation devices market is expected to reach $3.8 billion by 2028 from $2.6 billion in 2023 at a CAGR of 8.4%. The global market for sinus dilation devices is currently dominated by balloon dilation devices. The increased…

Read MoreGlobal Sinus Dilation Devices Market 2023 to 2028: Players Include Dalent Medical, Emos Technology, Entermed BV and Fentexmedical – ResearchAndMarkets.com

Multicancer Screening Global Market Report 2023: Need for Early Detection of Cancer Bolsters Growth – ResearchAndMarkets.com

The global multicancer screening market is projected to reach $7.78 billion by 2032 from $1.90 billion in 2022, growing at a CAGR of 15.09% during the forecast period 2023-2032. The growth in the global multicancer screening market is expected to…

Read MoreMulticancer Screening Global Market Report 2023: Need for Early Detection of Cancer Bolsters Growth – ResearchAndMarkets.com

IGC Pharma Secures $12 Million Line of Credit from O-Bank Strengthening Efforts in Alzheimer’s Research

IGC Pharma, Inc. (NYSE American: IGC) (“IGC” or the “Company”), a clinical-stage pharmaceutical company, has secured a $12 million revolving line of credit from the Hong Kong Branch of O-Bank Co., Ltd. (“O-Bank” or the “Bank”). This funding will support…

Read MoreIGC Pharma Secures $12 Million Line of Credit from O-Bank Strengthening Efforts in Alzheimer’s Research

Regen Lab partners with Morocco’s Ministries of Health and Industry, Dassault Systèmes, Baylor College of Medicine (US) and SOTHEMA to accelerate regenerative medicine in Morocco and Africa

Regen Lab, a Swiss medical technology company specializing in the research, development, registration, manufacturing and commercialization of proprietary tissue engineering products, announces the signing of a collaboration agreement with the Moroccan Ministries of Health and Industry, the Dassault Systèmes group…

Read MoreRegen Lab partners with Morocco’s Ministries of Health and Industry, Dassault Systèmes, Baylor College of Medicine (US) and SOTHEMA to accelerate regenerative medicine in Morocco and Africa

Braven Launches New Unit to Invest In the Next Generation of Healthcare & Life Science Innovators

Braven, an early stage investment firm focused on regulated ecosystems, today announced the launch of its new Healthcare & Life Sciences Unit, focusing on next-gen platforms merging machine intelligence and financial solutions to advance drug discovery and patient care. Co-led…

Read MoreBraven Launches New Unit to Invest In the Next Generation of Healthcare & Life Science Innovators

Novartis will appeal to U.S. Court of Appeals to uphold validity of Entresto® combination patent; maintains 2023 guidance and mid-term outlook

Novartis today announced that the U.S. District Court for the District of Delaware issued a negative decision regarding the validity of a patent covering Entresto and combinations of sacubitril and valsartan, which expires in 2025 with its pediatric exclusivity. Novartis…

Read MoreNovartis will appeal to U.S. Court of Appeals to uphold validity of Entresto® combination patent; maintains 2023 guidance and mid-term outlook